# GUI Agent Platform Core-Mate Secures Tens of Millions in Funding

- Category: Flash (快讯)
- Published: 2026-06-11T11:50:00.000Z
- Source date: 2026-06-11
- HTML: https://www.88z.ai/en/news/flash-20260611-4ef19e68b3c232e2
- Markdown: https://www.88z.ai/en/news/flash-20260611-4ef19e68b3c232e2.md
- Other language: https://www.88z.ai/news/flash-20260611-4ef19e68b3c232e2.md

GUI Agent execution platform Core-Mate has completed a funding round of tens of millions of yuan, exclusively invested by Dunhong Assets. Core team members are from ByteDance, having served as product managers for Douyin and Doubao. The platform enables AI to handle real operations in web pages and apps by integrating vision, control trees, and page states via the open-source OpenGUI framework for stable screen semantic understanding.

## At a glance

- Core-Mate secures tens of millions in exclusive funding from Dunhong Assets
- Achieves stable screen semantic understanding via the OpenGUI framework

## The update

The GUI Agent execution platform Core-Mate recently announced the completion of a funding round amounting to tens of millions of RMB, with exclusive investment from Dunhong Assets. The core members of the founding team come from ByteDance, where they served as product managers for well-known products such as Douyin and Doubao, bringing extensive experience in internet product development. Technologically, Core-Mate is dedicated to enabling artificial intelligence to truly take over actual operational tasks within web pages and applications. Its core technology is based on the open-source OpenGUI framework, which integrates visual information, control tree structures, and page state data. This approach achieves stable semantic understanding of screen content, ensuring the accuracy and reliability of AI agents when performing complex interactions.

## Sources

- [Founder Park](https://mp.weixin.qq.com/s/VfCODLKOQwlITN4rt09y-w) (2026-06-11)

This article is an AI-assisted synthesis by 88Z AI based on the public sources below. Product claims and availability are attributed to their publishers. It does not represent independent testing or first-hand reporting.
